Pancreatic cancer: Clinical sciences

2,634views

Pancreatic cancer: Clinical sciences

Block 9 Gastrointestinal partial

Block 9 Gastrointestinal partial

Colon histology
Esophagus histology
Gallbladder histology
Liver histology
Pancreas histology
Small intestine histology
Stomach histology
Gastroesophageal reflux disease (GERD)
Barrett esophagus
Eosinophilic esophagitis (NORD)
Esophageal cancer
Mallory-Weiss syndrome
Esophageal atresia and tracheoesophageal fistula: Year of the Zebra
Achalasia
Achalasia: Year of the Zebra
Esophageal disorders: Clinical
Esophageal disorders: Pathology review
Esophagitis: Clinical
Gastroesophageal reflux disease (GERD): Clinical
Gastroesophageal reflux disease: Clinical sciences
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Plummer-Vinson syndrome
Gastrointestinal bleeding: Clinical
Gastrointestinal bleeding: Pathology review
Diffuse esophageal spasm
Scleroderma: Pathology review
Scleroderma
Boerhaave syndrome
Pediatric gastrointestinal bleeding: Clinical
Jaundice
Jaundice: Pathology review
Jaundice: Clinical
Neonatal jaundice: Clinical
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Cholestatic liver disease
Cirrhosis: Clinical
Hepatitis B and Hepatitis D virus
Viral hepatitis: Pathology review
Viral hepatitis: Clinical
Viral hepatitis
Cirrhosis
Cirrhosis: Clinical sciences
Cirrhosis: Pathology review
Portal hypertension
Pulmonary arterial hypertension (NORD)
Approach to ascites: Clinical sciences
Pancreatitis: Clinical
Hepatocellular carcinoma
Hepatocellular adenoma
Peptic ulcer
Peptic ulcer disease: Clinical sciences
Peptic ulcers and stomach cancer: Clinical
Zollinger-Ellison syndrome
Approach to melena and hematemesis: Clinical sciences
Acid reducing medications
Antidiarrheals
Acute pancreatitis
Pancreatitis: Pathology review
Chronic pancreatitis
Chronic pancreatitis: Clinical sciences
Pancreatic cancer
Pancreatic cancer: Clinical sciences
Pancreatic neuroendocrine neoplasms
Acute cholecystitis
Neuroendocrine tumors of the gastrointestinal system: Pathology review
MEN syndromes: Clinical
Multiple endocrine neoplasia: Pathology review
Diabetes mellitus: Clinical
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetes mellitus (Type 2): Clinical sciences
Bowel obstruction: Clinical
Bowel obstruction
Large bowel obstruction: Clinical sciences
Small bowel obstruction: Clinical sciences
Irritable bowel syndrome
Inflammatory bowel disease: Pathology review
Inflammatory bowel disease: Clinical
Inflammatory bowel disease (Crohn disease): Clinical sciences
Short bowel syndrome (NORD)
Small bowel ischemia and infarction
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Diverticular disease: Clinical
Abdominal hernias
Hernias: Clinical
Inguinal hernia
Abdominal trauma: Clinical
Intussusception
Rotavirus
Congenital gastrointestinal disorders: Pathology review
Intestinal atresia
Diarrhea: Clinical
Yersinia enterocolitica
Escherichia coli
Malabsorption: Clinical
Malabsorption syndromes: Pathology review
Celiac disease
Tropical sprue
Whipple's disease
Colorectal polyps and cancer: Pathology review
Diverticular disease: Pathology review
Gallbladder disorders: Pathology review
Biliary atresia
Crigler-Najjar syndrome
Gilbert's syndrome
Gallstone ileus
Colorectal cancer
Colorectal polyps
Femoral hernia
Crohn disease
Ulcerative colitis
Microscopic colitis
Ischemic colitis
Carcinoid syndrome
Diverticulosis and diverticulitis
Gastroenteritis
Zenker diverticulum
Gastritis
Gastric cancer
Gastric dumping syndrome
Oral candidiasis
Oral cancer
Norovirus
Anal fissure
Anal fistula
Anal fissure: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Pancreatic cancer is most commonly adenocarcinoma, though there are some other rare types such as neuroendocrine or lymphoma. Pancreatic adenocarcinomas are exocrine tumors and are most often located in the head of the pancreas. Unfortunately, pancreatic cancer has an insidious onset, making it difficult to detect. Staging is based on tumor size, invasion of lymph nodes or nearby structures like major blood vessels, and presence or absence of distant spread and metastasis. Staging ultimately determines if the tumor is resectable or not.

The first step in evaluating a patient with signs and symptoms suggestive of pancreatic cancer is to obtain a focused history and physical examination. Now, the tumor might grow large enough to compress or invade the biliary tree and cause biliary obstruction and cholangitis. Because of this, you should be on the lookout for any red flags, which are actually signs of biliary obstruction and cholangitis. These include fever, severe jaundice with pruritus, altered mental status, and signs of sepsis such as tachycardia and hypotension. If any of these signs are present, you must first stabilize the patient. This means that you might need to secure the airway, provide supplemental oxygen, establish IV access, and consider starting broad-spectrum IV antibiotics.

In addition, order an ultrasound to rule out gallstones, as well as a CT scan to evaluate the site and cause of biliary obstruction. Next, because the mortality rate associated with biliary obstruction is high, you’ll have to relieve the obstruction before proceeding with further diagnostic workup. To do this, you should order an emergent ERCP with stenting to actually diagnose the obstruction and treat it immediately. However, if the patient can’t undergo ERCP with stenting, place a percutaneous cholecystostomy tube instead.

Now, let’s switch gears and talk about patients without red flags. Because most pancreatic cancers are insidious, patients usually present with non-specific symptoms, such as fatigue, anorexia, weight loss, and painless jaundice; while epigastric and back pain can occur with tumor invasion. Additionally, the history might reveal some important risk factors, like biological male sex, age over 55, and smoking, as well as having diabetes or chronic pancreatitis.

Then, the physical exam might reveal cachexia, as well as hepatomegaly, ascites, or a firm, fixed, palpable, nontender epigastric mass. Some important signs you may see include Courvoisier sign, which is characterized by obstructive jaundice with a palpable, nontender gallbladder; as well as Trousseau syndrome, also known as migratory thrombophlebitis, where the patient may develop recurrent blood clots that cause venous inflammation, leading to redness and tenderness of the limbs.

Some high-yield facts to keep in mind! Some pancreatic cancers arise from genetic mutations that can be associated with cancer syndromes. Therefore, if a patient has a personal or family history of cancer syndromes like Lynch syndrome, Peutz-Jeghers syndrome, or von Hippel-Lindau syndrome, your clinical suspicion of pancreatic cancer must be high.

If the history and physical examination suggest pancreatic cancer, you should obtain baseline labs, including bilirubin, liver function tests or LFTs, and the tumor marker CA19-9; and order a CT of the abdomen and pelvis. Alright, now that you’ve ordered some diagnostic tests, let’s talk about how to use them to stage the cancer. Labs will usually reveal elevated bilirubin and LFTs, as well as positive CA 19-9, Keep in mind that tumor markers like CA 19-9 are not used to diagnose the cancer, but to establish a baseline level, which will help you monitor the treatment response and assess for recurrence in the future. If a pancreatic mass is visualized on CT, you should move on to endoscopic ultrasound or CT-guided tissue biopsy, which can confirm the diagnosis of pancreatic cancer. Then, the next step is to stage the tumor with CT, MRI, or PET CT.

Sources

  1. "Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology" J Natl Compr Canc Netw (2021)
  2. "Metastatic Pancreatic Cancer: ASCO Guideline Update" J Clin Oncol (2020)
  3. "NCCN Guidelines Updates: Pancreatic Cancer" J Natl Compr Canc Netw (2019)